Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention

Table 2

Serum levels of CK-MB, cTnI, h-FABP, NO, and vWF in the control groups, expressed as x̅ ± s.

	CK-MB (U/L)	cTnI (ng/mL)	h-FABP (ng/mL)	NO (μmol/L)	vWF (ng/ml)
Pre-PCI	11.25 ± 3.74	0.05 ± 0.18	0.84 ± 0.98	78.50 ± 3.75	2.18 ± 1.14
Post-PCI	16.02 ± 11.01	0.47 ± 0.19	0.90 ± 1.04	54.31 ± 4.97	2.62 ± 1.30
values	0.043	0.000	0.333	0.000	0.005

PCI: percutaneous coronary intervention, CK-MB: creatine kinase-muscle/brain, cTnI: cardiac troponin I, h-FABP: heart-type fatty acid-binding protein, vWF: von Willebrand factor, and NO: nitric oxide.